Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemetrexed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04895735
What this trial is testing

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Who this might be right for
Metastatic Salivary Gland CarcinomaRecurrent Salivary Gland CarcinomaStage IV Major Salivary Gland Cancer AJCC v8+1 more
Mayo Clinic 45
Testing effectiveness (Phase 2)Study completedNCT00407550
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 19
Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing

Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76
Testing effectiveness (Phase 2)Looking for participantsNCT06755684
What this trial is testing

Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer

Who this might be right for
EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung Cancer+5 more
Peng Zhang 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06305754
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 550
Testing effectiveness (Phase 2)Ended earlyNCT00203931
What this trial is testing

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Chicago 55
Large-scale testing (Phase 3)Study completedNCT04194203
What this trial is testing

Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 305
Large-scale testing (Phase 3)Study completedNCT03134872
What this trial is testing

SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more
Jiangsu HengRui Medicine Co., Ltd. 419
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Large-scale testing (Phase 3)Ended earlyNCT01282151
What this trial is testing

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
Chonnam National University Hospital 148
Testing effectiveness (Phase 2)Study completedNCT04107103
What this trial is testing

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Who this might be right for
SCCHN
AHS Cancer Control Alberta 6
Testing effectiveness (Phase 2)Study completedNCT00550173
What this trial is testing

Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 247
Testing effectiveness (Phase 2)Study completedNCT00461786
What this trial is testing

Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cancer
Eli Lilly and Company 51
Testing effectiveness (Phase 2)Study completedNCT00541073
What this trial is testing

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Centre Oscar Lambret 60
Early research (Phase 1)Study completedNCT01323062
What this trial is testing

Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
UNC Lineberger Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT06304441
What this trial is testing

Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer

Who this might be right for
Leptomeningeal Metastasis
Guangzhou Medical University 100
Large-scale testing (Phase 3)Study completedNCT02578680
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)

Who this might be right for
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 616
Not applicableEnrolling By InvitationNCT07450040
What this trial is testing

Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma

Who this might be right for
ORROSPFS
Eye & ENT Hospital of Fudan University 60
Testing effectiveness (Phase 2)Study completedNCT00330915
What this trial is testing

Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

Who this might be right for
Rectal Neoplasms
Eli Lilly and Company 37
Testing effectiveness (Phase 2)UnknownNCT04453423
What this trial is testing

Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
The First Affiliated Hospital with Nanjing Medical University 90
Next Page